CZ214492A3 - 2-(2-substituted pyrrolidinylthio)carbapenem derivatives - Google Patents

2-(2-substituted pyrrolidinylthio)carbapenem derivatives Download PDF

Info

Publication number
CZ214492A3
CZ214492A3 CS922144A CS214492A CZ214492A3 CZ 214492 A3 CZ214492 A3 CZ 214492A3 CS 922144 A CS922144 A CS 922144A CS 214492 A CS214492 A CS 214492A CZ 214492 A3 CZ214492 A3 CZ 214492A3
Authority
CZ
Czechia
Prior art keywords
group
methyl
ylthio
compound
hydroxyethyl
Prior art date
Application number
CS922144A
Other languages
Czech (cs)
English (en)
Inventor
Nakagawa Susumu
Ohtake Norikazu
Okada Shigemitsu
Ushijima Ryosuke
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of CZ214492A3 publication Critical patent/CZ214492A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS922144A 1991-07-09 1992-07-09 2-(2-substituted pyrrolidinylthio)carbapenem derivatives CZ214492A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19476791 1991-07-09
JP34959191 1991-12-07

Publications (1)

Publication Number Publication Date
CZ214492A3 true CZ214492A3 (en) 1993-01-13

Family

ID=26508721

Family Applications (1)

Application Number Title Priority Date Filing Date
CS922144A CZ214492A3 (en) 1991-07-09 1992-07-09 2-(2-substituted pyrrolidinylthio)carbapenem derivatives

Country Status (12)

Country Link
EP (1) EP0522504A1 (cg-RX-API-DMAC7.html)
KR (1) KR930702353A (cg-RX-API-DMAC7.html)
AU (1) AU646577B2 (cg-RX-API-DMAC7.html)
CA (1) CA2073377A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ214492A3 (cg-RX-API-DMAC7.html)
FI (1) FI931015A0 (cg-RX-API-DMAC7.html)
IE (1) IE922225A1 (cg-RX-API-DMAC7.html)
IL (1) IL102453A (cg-RX-API-DMAC7.html)
NO (1) NO930844L (cg-RX-API-DMAC7.html)
TW (1) TW206226B (cg-RX-API-DMAC7.html)
WO (1) WO1993001192A1 (cg-RX-API-DMAC7.html)
YU (1) YU68292A (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216102D0 (en) * 1992-07-29 1992-09-09 Smithkline Beecham Plc Pharmaceutical substances
KR950014111A (ko) * 1993-11-23 1995-06-15 유충식 새로운 카바페넴 유도체 및 그 제조방법
KR970010769A (ko) * 1995-08-01 1997-03-27 유충식 카바페넴 유도체의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
AU631671B2 (en) * 1989-08-04 1992-12-03 Banyu Pharmaceutical Co., Ltd. 2-(2-vinylpyrrolidinylthio)carbapenem derivatives

Also Published As

Publication number Publication date
YU68292A (sh) 1995-03-27
WO1993001192A1 (en) 1993-01-21
NO930844L (no) 1993-05-07
CA2073377A1 (en) 1993-01-10
IE922225A1 (en) 1993-01-13
EP0522504A1 (en) 1993-01-13
KR930702353A (ko) 1993-09-08
NO930844D0 (no) 1993-03-08
FI931015A7 (fi) 1993-03-08
FI931015A0 (fi) 1993-03-08
TW206226B (cg-RX-API-DMAC7.html) 1993-05-21
AU646577B2 (en) 1994-02-24
IL102453A0 (en) 1993-01-14
IL102453A (en) 1996-01-19
AU1947192A (en) 1993-01-14

Similar Documents

Publication Publication Date Title
FI84826C (fi) Foerfarande foer framstaellning av 6 -(1-hydroxietyl-2-substituerad-2-karbapenem-3-karboxylsyror anvaendbara som laekemedel.
FI96863C (fi) Menetelmä lääkeaineina käyttökelpoisten /2-(1-homopiperatsiinikarbonyyli)pyrrolidin-4-yylitio/-6-(1-hydroksietyyli)-1-karbapen-2-eemi-3-karboksylaattisuolojen valmistamiseksi
DE69523574T2 (de) Carbapenem-derivate
EP0182213A1 (en) Carbapenem compounds and production thereof
HU196800B (en) Process for producing carbepeneme derivatives and pharmaceutical compositions containing them as active component
CZ167792A3 (en) 1-methylcarbapenem derivatives process of their preparation and use
DE69121259T2 (de) Beta-Lactam-Verbindungen und ihre Herstellung
DE69623497T2 (de) 1-methylcarbapenem-derivate
HU196071B (en) Process for production of carbopenems and medical compounds containing such compositions
RU2162088C2 (ru) 1-метилкарбапенем или его фармакологически приемлемые соли, композиция, способ предупреждения или лечения бактериальных инфекций
EP0449191B1 (en) 2-(Substituted pyrrolidinylthio)carbapenem derivatives
CA2083980C (en) Aminoalkylpyrrolidinylthiocarbapenem derivatives
JP3367126B2 (ja) アミノアルキルピロリジニルチオカルバペネム誘導体
EP0773222A1 (en) Novel carbapenem derivative
JPH07291973A (ja) 新規な2−ピロリジニルチオカルバペネム誘導体
WO1995014692A1 (en) Cabapenem derivatives and processes for preparing the same
EP0522504A1 (en) 2-(2-substituted pyrrolidinylthio)-carbapenem derivatives
KR100231497B1 (ko) (1s, 5r, 6s)-2-치환된 히드록시메틸-6-[(1r)-1-히드록시에틸]-1-메틸-2-카르바페넴-3-카르복실산 유도체 및 그의 제조 방법
JPH04321688A (ja) 2−(置換ピロリジニルチオ)カルバペネム誘導体
EP0658162A1 (en) Carbapenem derivatives and processes for preparing the same
JPH05213954A (ja) 2−(2−置換ピロリジニルチオ)カルバペネム誘導体
JP2000143512A (ja) メタロ―β―ラクタマ―ゼ阻害剤
JPH054988A (ja) 2−(置換ピロリジニルチオ)カルバペネム誘導体
JPH04134082A (ja) 2−(2−シクロプロピルピロリジン−4−イルチオ)カルバペネム誘導体
WO1993006102A1 (fr) Derive de 2-(pyrrolidinylthio substitue) carbapenem